NYSEMKT: VTAK
Catheter Precision Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their VTAK stock forecasts and price targets.

Forecast return on equity

Is VTAK forecast to generate an efficient return?

Company
N/A
Industry
22.68%
Market
67.39%

Forecast return on assets

Is VTAK forecast to generate an efficient return on assets?

Company
N/A
Industry
12.02%

VTAK earnings per share forecast

What is VTAK's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$6.30

VTAK vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
VTAK$0.37N/AN/A
XYLO$4.96N/AN/A
HSCS$3.57$13.00+263.84%Strong Buy
AMIX$1.30$5.00+284.62%Strong Buy
VERO$2.51N/AN/A

Catheter Precision Stock Forecast FAQ

What is VTAK's earnings growth forecast for 2025-2025?

(NYSEMKT: VTAK) Catheter Precision's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 21.05%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.71%.

Catheter Precision's earnings in 2025 is -$23,171,000.

In 2025, VTAK is forecast to generate -$69,408,977 in earnings, with the lowest earnings forecast at -$69,408,977 and the highest earnings forecast at -$69,408,977.

If you're new to stock investing, here's how to buy Catheter Precision stock.

What is VTAK's forecast return on equity (ROE) for 2025-2027?

(NYSEMKT: VTAK) forecast ROE is N/A, which is considered weak.

What is VTAK's Earnings Per Share (EPS) forecast for 2025-2025?

(NYSEMKT: VTAK) Catheter Precision's current Earnings Per Share (EPS) is -$5.34. In 2025, VTAK's EPS is forecast to hit -$6.30 (min: -$6.30, max: -$6.30).

What is VTAK's forecast return on assets (ROA) for 2025-2027?

(NYSEMKT: VTAK) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 12.02%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.